On July 30, 2025, GSK plc purchased 288,978 ordinary shares at an average price of 1,432.69 pence as part of its ongoing buyback program, bringing the total shares purchased since June 4, 2025, to 18,435,938. After this transaction, GSK holds 236,570,321 shares in treasury and has 4,078,815,089 shares in issue, accounting for 5.80% voting rights held in treasury.